Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide in Friedreich's ataxia
2017-002163-17Phase 2Terminated
- Sponsor
- RWTH Aachen University
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Friedreich ataxia (FA) comparing Nicotinamide with Placebo (2 arms). Primary endpoint: Change in the Scale for the Assessment and Rating of Ataxia. Started Nov 2017; status: terminated.
02
Drugs
nicotinamide
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2017-002163-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002163-17.